Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned?
Motley Fool
Wed, 05/18/22 - 10:26 am
Pfizer
COVID-19
Paxlovid
LabCorp becomes first company to get EUA for direct-to-consumer test for flu, RSV, COVID-19
Medtech Dive
Wed, 05/18/22 - 10:14 am
Medtech
diagnostics
COVID-19
Flu
RSV
FDA
LapCorp
Emergency Use Authorization
FDA clears Covid booster shot for healthy kids ages 5 to 11
Stat
Tue, 05/17/22 - 10:34 pm
COVID-19
vaccines
FDA
boosters
pediatric
Pfizer
BioNTech
Pfizer, Merck, AstraZeneca led Big Pharma's growth in Q1 but they couldn't match mRNA hotshots
Fierce Pharma
Tue, 05/17/22 - 10:43 am
Big Pharma
earnings
Pfizer
Merck
AstraZeneca
COVID-19
Moderna Therapeutics
BioNTech
AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup
Endpoints
Tue, 05/17/22 - 10:36 am
AstraZeneca
COVID-19
antibodies
RQ Biotechnology
Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
R&D
licensing
M&A
COVID-19
Big Pharma
Bristol Myers Squibb
JNJ
AbbVie
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Roche
GSK
Eli Lilly
FDA rejects antidepressant seen as possible Covid-19 treatment
Stat
Mon, 05/16/22 - 07:45 pm
FDA
COVID-19
antidepressants
fluvoxamine
Pfizer’s Covid Vaccine Protection Against Omicron Fades Just Weeks After Second And Third Doses, Study Finds
Forbes
Fri, 05/13/22 - 11:56 am
Pfizer
vaccines
COVID-19
Omicron variant
Global license program to receive Covid-19 support from the NIH
Endpoints
Fri, 05/13/22 - 10:45 am
WHO
Joe Biden
NIH
COVID-19
Medicines Patent Pool
This Is the Most Important Number From Novavax's Q1 Earnings
Motley Fool
Fri, 05/13/22 - 10:40 am
Novavax
earnings
vaccines
COVID-19
FDA approves new indication for drug to treat severe COVID-19
Beckers Hospital Review
Thu, 05/12/22 - 10:51 pm
Eli Lilly
Incyte
baricitinib
FDA
olumiant
COVID-19
Pfizer 'intensively researching' long-lasting COVID-19 vaccine
Beckers Hospital Review
Thu, 05/12/22 - 10:48 pm
Pfizer
Albert Bourla
vaccines
COVID-19
Pfizer partner Biovac warns of production slump amid low COVID vaccine demand: report
Fierce Pharma
Thu, 05/12/22 - 10:46 pm
Pfizer
Biovac
BioNTech
vaccines
COVID-19
Merck KGaA warns of volatile 2022 thanks to war in Ukraine and fresh COVID lockdowns in China
Fierce Pharma
Thu, 05/12/22 - 10:49 am
Merck KGaA
Ukraine
Russia
China
COVID-19
Is Paxlovid, the Covid pill, reaching those who most need it? The government won’t say
Endpoints
Thu, 05/12/22 - 10:19 am
Pfizer
Paxlovid
COVID-19
Moderna Vaccine Provokes Strong Immune Response in Children 6 to 11
NY Times, NY
Wed, 05/11/22 - 11:00 pm
Moderna Therapeutics
pediatric
vaccines
COVID-19
Rising Google searches for certain procedures suggest recovering demand at medtechs: analysts
Medtech Dive
Wed, 05/11/22 - 10:53 am
Google
Medtech
devices
surgery
elective procedures
pandemic
COVID-19
Emergent hid COVID-19 vaccine problems from FDA, report finds
Beckers Hospital Review
Tue, 05/10/22 - 10:31 pm
Emergent BioSolutions
vaccines
COVID-19
government contracts
ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost effective, but their benefits are far from equal
Fierce Pharma
Tue, 05/10/22 - 10:50 am
ICER
Pfizer
Paxlovid
Merck
Ridgeback Biotherapeutics
molnupiravir
COVID-19
After racking up 41 Covid jab nods outside US, Novavax hits first profitable quarter but still disappoints investors
Endpoints
Tue, 05/10/22 - 10:48 am
Novavax
COVID-19
earnings
vaccines
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »